1. Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo

   • T. Haferlach
   • W. Gassmann
   • T. Büchner for the AML Cooperative Group

   Original Article Pages: 165 - 170

2. Reproducibility of the morphological diagnostic criteria for acute myeloid leukemia: the GIMEMA group experience

   • G. L. Castoldi
   • V. Liso
   • F. Mandelli

   Original Article Pages: 171 - 174

3. Serial changes in endogenous erythropoietin levels in patients with myelodysplastic syndromes and aplastic anemia undergoing erythropoietin treatment

   • Y. Yoshida
   • N. Anzai
   • M. Okuma

   Original Article Pages: 175 - 180

4. Treatment of aplastic anemia with a monoclonal antibody directed against the interleukin-2 receptor

   • W. Schwinger
   • C. Urban
   • C. Mache

   Original Article Pages: 181 - 184

5. Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony-stimulating factor

   • A. Riccardi
   • M. Danova
   • E. Ascari

   Original Article Pages: 185 - 193

6. Acute sterile inflammation — correlation between cellular changes and extramedullary-produced regulators in vivo

   • G. Jovčić
   • N. Stojanović
   • P. Obradović

   Original Article Pages: 195 - 201

7. Relation between bone marrow hemosiderin iron, serum iron status markers, and chemical and histochemical liver iron content in 82 patients with alcoholic and nonalcoholic hepatic disease

   • N. Milman
   • N. Graudal
   • N. Strandberg Pedersen

   Original Article Pages: 203 - 207

8. Treatment of the hematological manifestations of dyskeratosis congenita

   • C. Putterman
   • R. Safadi
   • A. Eldor

   Case Report Pages: 209 - 212

9. The appearance of reticulocytes with medium or high RNA content is a sensitive indicator of beginning granulocyte recovery after aplasiogenic cytostatic drug therapy in patients with AML

   • R. Kuse

   Case Report Pages: 213 - 214

10. Change of paraprotein from IgG lambda to lambda chain in myeloma

    • M. Sawamura
    • K. Murayama
    • J. Tsuchiya

    Case Report Pages: 215 - 216

11. Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF — clinical attention

    • S. Iki
    • K. Yoshinaga
    • A. Urabe

    Letter to the Editor Pages: 217 - 218